Literature DB >> 15735788

Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis.

Ali Al-Shanqeeti1, Astrid van Hylckama Vlieg, Erik Berntorp, Frits R Rosendaal, George J Broze.   

Abstract

To assess the potential roles of protein Z (PZ) and protein Z-dependent protease inhibitor (ZPI) in venous thrombosis, their plasma levels were measured in 426 individuals with venous thrombosis and 471 control individuals participating in the Leiden Thrombophilia Study. A relationship between the level of PZ or ZPI and venous thrombosis was not detected in the overall case-control study. PZ and ZPI circulate as a complex and their plasma levels are interdependent. Both PZ and ZPI are increased with oral contraceptive use and reduced with oral anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735788     DOI: 10.1160/TH04-11-0715

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  23 in total

1.  Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects.

Authors:  Dora Fabbro; Giovanni Barillari; Giuseppe Damante
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 2.  A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; George Broze; Sandra Fedi
Journal:  Thromb Haemost       Date:  2010-01-13       Impact factor: 5.249

3.  Computational study of the putative active form of protein Z (PZa): sequence design and structural modeling.

Authors:  Vasu Chandrasekaran; Chang Jun Lee; Robert E Duke; Lalith Perera; Lee G Pedersen
Journal:  Protein Sci       Date:  2008-05-20       Impact factor: 6.725

4.  Low protein Z levels in children with nephrotic syndrome.

Authors:  Ozan Ozkaya; Kenan Bek; Tunc Fişgin; Yuksel Aliyazicioğlu; Sevinc Sultansuyu; Yonca Açikgöz; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

5.  Association of the R67X and W303X non-sense polymorphisms in the protein Z-dependent protease inhibitor gene with idiopathic recurrent miscarriage.

Authors:  F S AlShaikh; R R Finan; A W Almawi; F E Mustafa; W Y Almawi
Journal:  Mol Hum Reprod       Date:  2011-10-27       Impact factor: 4.025

6.  Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Authors:  T J Girard; N M Lasky; K Grunz; G J Broze
Journal:  J Thromb Haemost       Date:  2018-12-16       Impact factor: 5.824

7.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

8.  Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.

Authors:  Jing Zhang; Yizheng Tu; Lan Lu; Nina Lasky; George J Broze
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

9.  Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.

Authors:  T J Girard; N M Lasky; E A Tuley; G J Broze
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

10.  Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Ioannis Asproudis; Taxiarchis L Felekis; Spiridon Gorezis; Lefkothea Dova; Eleni Dokou; Georgios Vartholomatos; Miltiadis Aspiotis; Nikolaos I Kolaitis
Journal:  Open Ophthalmol J       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.